Otsuka Subsidiary To Expand High-Potency ManufacturingBy
Taiho Pharmaceutical, part of the Japanese pharmaceutical company, Otsuka. broke ground for the construction of a new building for the production of highly potent active pharmaceutical ingredients at its site in Saitama, Japan.
The company plans to produce highly potent active pharmaceutical ingredients for anticancer drugs, The building, which will have a floor area of 4,700 square meters, is expected is to be completed in June 2018, and operations are expected to begin in the new building in October 2018.
Source: Taiho Pharmaceutical